Letter to the Editor
Response to letter "Do all hypnotic drugs and sedatives have risk for cancer?"
To the Editor:
Iqbal and colleagues analyzed Asian data on three hypnotic/ sedative drugs and overall risk of cancer [1] . They found that nitrazepam had a nonsignificant association (adjusted odds ratio [AOR], 0.98; 95% confidence interval [CI], 0.80-1.21), while flunitrazepam (AOR, 1.16; 95% CI, 1.04-1.30) and lorametazepam (AOR, 1.19; 95% CI, 1.02-1.38) had a statistically significant association with cancer. They concluded that nitrazepam may be safer than other hypnotics in terms of carcinogenicity. We used metaanalysis to evaluate whether the relative risk ratios reported by YuChuan indeed differ from each other. The I2 statistic was 20.8% (p = 0.283), suggesting that this was not the case. Given the lack of statistical evidence, we urge caution in interpreting nitrazepam as a safer drug. 
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